| 000 | 01705 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517191456.0 | ||
| 264 | 0 | _c20190726 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1433-0350 | ||
| 024 | 7 |
_a10.1007/s00381-017-3690-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbu Arja, Mohammad H | |
| 245 | 0 | 0 |
_aBrentuximab-vedotin maintenance following chemotherapy without irradiation for primary intracranial embryonal carcinoma in down syndrome. _h[electronic resource] |
| 260 |
_bChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery _c04 2018 |
||
| 300 |
_a777-780 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBrentuximab Vedotin |
| 650 | 0 | 4 |
_aCarcinoma, Embryonal _xcomplications |
| 650 | 0 | 4 |
_aCentral Nervous System Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDown Syndrome _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoconjugates |
| 650 | 0 | 4 |
_aKi-1 Antigen _xmetabolism |
| 650 | 0 | 4 |
_aKi-67 Antigen _xmetabolism |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 |
_aOctamer Transcription Factor-3 _xmetabolism |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aConley, Suzanne E | |
| 700 | 1 | _aSalceda, Violeta | |
| 700 | 1 | _aAl-Sufiani, Fahd | |
| 700 | 1 | _aBoué, Daniel R | |
| 700 | 1 | _aFinlay, Jonathan L | |
| 773 | 0 |
_tChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery _gvol. 34 _gno. 4 _gp. 777-780 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00381-017-3690-9 _zAvailable from publisher's website |
| 999 |
_c27884629 _d27884629 |
||